# Aster DM Health (NSE: ASTERDM) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/ASTERDM · Pivot · prices to 21 Oct 2026

Aster DM Health (NSE: ASTERDM) closed at ₹650.40 on 21 Oct 2026, down 0.06% on the day. With a market capitalisation of ₹58,210 Cr, it ranks 177th by market cap among the 4,183 NSE companies Pivot tracks (a mid-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.

At its last close the stock traded at 104.3× trailing earnings, against a return on equity of 8.5% in FY26. Over the past year the share price has fallen 4.8%. Its 52-week range is ₹519.10 (4 Feb 2026) to ₹891.30 (10 Aug 2026); the last close is 27.0% below the high.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹650.40 |
| Market cap | ₹58,210 Cr |
| P/E (trailing) | 104.3 |
| ROE | 8.5% (FY26) |
| ROCE | 10.7% (FY26) |
| Debt to equity | 0.15 |
| 52-week high | ₹891.30 (10 Aug 2026) |
| 52-week low | ₹519.10 (4 Feb 2026) |
| 1-year return | −4.8% |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹4,138 Cr | ₹5,427 Cr |
| FY24 | ₹3,699 Cr | ₹223 Cr |
| FY23 | ₹11,933 Cr | ₹474 Cr |
| FY22 | ₹10,253 Cr | ₹601 Cr |
| FY21 | ₹8,608 Cr | ₹174 Cr |
| FY20 | ₹8,739 Cr | ₹315 Cr |

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Glenmark Pharmaceuticals](https://app.pivotnow.in/stock/GLENMARK) | ₹2,214.30 | ₹62,488 Cr | 45.8 | 12.9% |
| [Alkem Laboratories](https://app.pivotnow.in/stock/ALKEM) | ₹5,016.00 | ₹59,974 Cr | 26.1 | 16.6% |
| [Fortis Healthcare](https://app.pivotnow.in/stock/FORTIS) | ₹736.65 | ₹55,614 Cr | 53.5 | 10.5% |
| [Biocon](https://app.pivotnow.in/stock/BIOCON) | ₹340.35 | ₹55,467 Cr | 120.3 | 1.1% |
| [Abbott India](https://app.pivotnow.in/stock/ABBOTINDIA) | ₹25,895.00 | ₹55,025 Cr | 35.4 | 33.4% |
| [Gland Pharma](https://app.pivotnow.in/stock/GLAND) | ₹2,975.90 | ₹49,090 Cr | 47.8 | 9.9% |

## Questions and answers

### What is the share price of Aster DM Health today?

Aster DM Health (NSE: ASTERDM) last closed at ₹650.40 on 21 Oct 2026. Its 52-week high is ₹891.30 and its 52-week low is ₹519.10.

### What is the market cap of Aster DM Health?

Aster DM Health's market capitalisation is ₹58,210 Cr (₹58,210 Cr) at the 21 Oct 2026 close, ranking 177th among the NSE companies Pivot tracks.

### What is the P/E ratio of Aster DM Health?

Aster DM Health trades at a trailing P/E of 104.3. The median P/E of the 6 closest Pharma & Healthcare peers by market cap is 47.8.

### What is the ROE and ROCE of Aster DM Health?

Return on equity was 8.5% in FY26 and return on capital employed was 10.7% in FY26 (consolidated figures).

### Is Aster DM Health a debt-free company?

No. Aster DM Health's debt-to-equity ratio was 0.15 in FY26, with total debt of ₹2,299 Cr.

### How has Aster DM Health stock performed over the last year?

Aster DM Health's share price has fallen 4.8% over the past year, −18.2% over three months and −11.3% over one month, to the 21 Oct 2026 close.

### Who are Aster DM Health's competitors?

The listed Pharma & Healthcare companies closest to Aster DM Health by market cap are Glenmark Pharmaceuticals, Alkem Laboratories, Fortis Healthcare, Biocon, Abbott India and Gland Pharma.

### Is Aster DM Health a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Aster DM Health's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on ASTERDM against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.